Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$31.72
-0.8%
$31.54
$25.86
$39.08
$281.93M1.4725,386 shs20,366 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$4.48
+5.7%
$4.26
$0.52
$5.92
$294.85M1.97688,864 shs853,063 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.44
+0.2%
$11.24
$8.56
$22.40
$262.88M2.14221,897 shs76,656 shs
Zynex, Inc. stock logo
ZYXI
Zynex
$2.41
-4.4%
$3.99
$1.93
$12.19
$72.85M1.09151,440 shs158,812 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
+5.86%+8.70%+2.53%-13.82%-1.57%
Neuronetics, Inc. stock logo
STIM
Neuronetics
+1.19%+12.77%-2.97%+73.77%+13.07%
ZimVie Inc. stock logo
ZIMV
ZimVie
+0.43%+0.32%-19.69%-34.40%-40.42%
Zynex, Inc. stock logo
ZYXI
Zynex
+3.28%+15.60%-0.79%-69.86%-77.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.7479 of 5 stars
3.51.00.00.01.91.70.6
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.1785 of 5 stars
2.32.00.00.01.91.70.6
ZimVie Inc. stock logo
ZIMV
ZimVie
2.5772 of 5 stars
3.53.00.00.02.81.70.6
Zynex, Inc. stock logo
ZYXI
Zynex
3.0372 of 5 stars
3.21.00.00.01.72.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$48.5052.90% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5022.77% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
3.00
Buy$19.50106.57% Upside
Zynex, Inc. stock logo
ZYXI
Zynex
2.33
Hold$10.25325.31% Upside

Current Analyst Ratings Breakdown

Latest ZYXI, STIM, SMTI, and ZIMV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$46.00 ➝ $46.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $51.00
3/13/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$11.00 ➝ $5.50
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/5/2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$5.00 ➝ $8.00
(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$86.67M3.25N/AN/A$5.22 per share6.08
Neuronetics, Inc. stock logo
STIM
Neuronetics
$74.89M3.94N/AN/A$1.18 per share3.80
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.58$3.41 per share2.77$15.43 per share0.61
Zynex, Inc. stock logo
ZYXI
Zynex
$192.35M0.38$0.13 per share18.01$1.36 per share1.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$4.30M-$1.14N/AN/AN/A-10.71%-19.86%-10.91%5/14/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$30.19M-$1.37N/AN/AN/A-50.09%-141.24%-32.77%5/6/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$393.28M-$0.95N/AN/A-77.31%2.90%1.17%5/14/2025 (Estimated)
Zynex, Inc. stock logo
ZYXI
Zynex
$9.73M$0.0916.075.13N/A2.49%13.05%3.78%4/28/2025 (Estimated)

Latest ZYXI, STIM, SMTI, and ZIMV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.31N/AN/AN/A$23.48 millionN/A
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13N/AN/AN/A$29.07 millionN/A
4/28/2025Q1 2025
Zynex, Inc. stock logo
ZYXI
Zynex
-$0.24N/AN/AN/A$30.83 millionN/A
3/25/2025Q4 2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.19-$0.18+$0.01-$0.18$22.75 million$26.31 million
3/11/2025Q4 2024
Zynex, Inc. stock logo
ZYXI
Zynex
$0.09-$0.02-$0.11-$0.02$53.65 million$45.98 million
2/26/2025Q4 2024
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.25$0.27+$0.02-$0.43$113.67 million$111.52 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
0.76
2.23
2.02
Neuronetics, Inc. stock logo
STIM
Neuronetics
4.90
3.16
2.87
ZimVie Inc. stock logo
ZIMV
ZimVie
0.57
1.94
1.38
Zynex, Inc. stock logo
ZYXI
Zynex
1.66
3.94
3.15

Institutional Ownership

CompanyInstitutional Ownership
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%
Zynex, Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
54.10%
Neuronetics, Inc. stock logo
STIM
Neuronetics
9.80%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
Zynex, Inc. stock logo
ZYXI
Zynex
49.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
608.89 million4.01 millionNot Optionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18065.82 million27.37 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
2,70027.85 million26.77 millionOptionable
Zynex, Inc. stock logo
ZYXI
Zynex
77030.23 million15.25 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Sanara MedTech stock logo

Sanara MedTech NASDAQ:SMTI

$31.72 -0.27 (-0.84%)
Closing price 04:00 PM Eastern
Extended Trading
$31.25 -0.47 (-1.48%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$4.48 +0.24 (+5.66%)
Closing price 04:00 PM Eastern
Extended Trading
$4.44 -0.04 (-0.89%)
As of 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.44 +0.02 (+0.21%)
Closing price 04:00 PM Eastern
Extended Trading
$9.44 0.00 (-0.05%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Zynex stock logo

Zynex NASDAQ:ZYXI

$2.41 -0.11 (-4.37%)
Closing price 04:00 PM Eastern
Extended Trading
$2.49 +0.08 (+3.32%)
As of 05:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.